WOBURN, Mass.--(BUSINESS WIRE)--Mar 5, 2009 - ArQule, Inc. (NASDAQ: ARQL) today announced the expansion of its clinical development program for ARQ 197, a proprietary, orally administered small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback